Abrogation of Vif function by peptide derived from the N-terminal region of the human immunodeficiency virus type 1 (HIV-1) protease

Virology

Volumn 330, Issue 1, 2004, Pages 261-270

  Hutoran, Marina ^a   Britan, Elena ^a   Baraz, Lea ^a   Blumenzweig, Immanuel ^a   Steinitz, Michael ^a   Kotler, Moshe ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

APOBEC3G; HIV 1; HIV 1 protease; Synthetic peptides; Vif

Indexed keywords

AMINO ACID; PEPTIDE; PROTEINASE; VIF PROTEIN; VIRUS ENZYME;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; COVALENT BOND; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

BASE SEQUENCE; BETA-GALACTOSIDASE; DNA PRIMERS; GENE PRODUCTS, VIF; HELA CELLS; HIV PROTEASE; HIV-1; HUMANS; LYMPHOCYTES; PEPTIDE FRAGMENTS; RECOMBINANT FUSION PROTEINS; TRANSFECTION;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 7444246113     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.09.029     Document Type: Article

References (57)

1. G.M. Aldrovandi, and J.A. Zack Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice J. Virol. 70 3 1996 1505 1511
2. L. Baraz, and M. Kotler The Vif protein of human immunodeficiency virus type 1 (HIV-1): enigmas and solutions Curr. Med. Chem. 11 2 2004 221 231
3. L. Baraz, A. Friedler, I. Blumenzweig, O. Nussinuv, N. Chen, M. Steinitz, C. Gilon, and M. Kotler Human immunodeficiency virus type 1 Vif-derived peptides inhibit the viral protease and arrest virus production FEBS Lett. 441 3 1998 419 426
4. L. Baraz, M. Hutoran, I. Blumenzweig, M. Katzenellenbogen, A. Friedler, C. Gilon, M. Steinitz, and M. Kotler Human immunodeficiency virus type 1 Vif binds the viral protease by interaction with its N-terminal region J. Gen. Virol. 83 Pt 9 2002 2225 2230
5. M. Bardy, B. Gay, S. Pebernard, N. Chazal, M. Courcoul, R. Vigne, E. Decroly, and P. Boulanger Interaction of human immunodeficiency virus type 1 Vif with Gag and Gag-Pol precursors: co-encapsidation and interference with viral protease-mediated Gag processing J. Gen. Virol. 82 Pt 11 2001 2719 2733
6. I. Blumenzweig, L. Baraz, A. Friedler, U.H. Danielson, C. Gilon, M. Steinitz, and M. Kotler HIV-1 Vif-derived peptide inhibits drug-resistant HIV proteases Biochem. Biophys. Res. Commun. 292 4 2002 832 840
7. A.M. Borman, C. Quillent, P. Charneau, C. Dauguet, and F. Clavel Human immunodeficiency virus type 1 Vif-mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity J. Virol. 69 4 1995 2058 2067
8. M. Bouyac, F. Rey, M. Nascimbeni, M. Courcoul, J. Sire, D. Blanc, F. Clavel, R. Vigne, and B. Spire Phenotypically Vif-human immunodeficiency virus type 1 is produced by chronically infected restrictive cells J. Virol. 71 3 1997 2473 2477
9. S.G. Conticello, R.S. Harris, and M.S. Neuberger The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G Curr. Biol. 13 22 2003 2009 2013
10. B. Cullen Use of eukariotic expression technology in the functional analysis of cloned genes Methods Enzymol. 152 1987 693 694
11. R.C. Desrosiers HIV with multiple gene deletions as a live attenuated vaccine for AIDS AIDS Res. Hum. Retroviruses 8 8 1992 1457
12. A.G. Fisher, E. Collalti, L. Ratner, R.C. Gallo, and F. Wong-Staal A molecular clone of HTLV-III with biological activity Nature 316 6025 1985 262 265
13. A.G. Fisher, B. Ensoli, L. Ivanoff, M. Chamberlain, S. Petteway, L. Ratner, R.C. Gallo, and F. Wong-Staal The sor gene of HIV-1 is required for efficient virus transmission in vitro Science 237 4817 1987 888 893
14. R.A. Fouchier, J.H. Simon, A.B. Jaffe, and M.H. Malim Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins J. Virol. 70 12 1996 8263 8269
15. A. Friedler, I. Blumenzweig, L. Baraz, M. Steinitz, M. Kotler, and C. Gilon Peptides derived from HIV-1 Vif: a non-substrate based novel type of HIV-1 protease inhibitors J. Mol. Biol. 287 1 1999 93 101
16. D.H. Gabuzda, K. Lawrence, E. Langhoff, E. Terwilliger, T. Dorfman, W.A. Haseltine, and J. Sodroski Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes J. Virol. 66 11 1992 6489 6495
17. R.S. Harris, S.K. Petersen-Mahrt, and M.S. Neuberger RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators Mol. Cell 10 5 2002 1247 1253
18. R.S. Harris, K.N. Bishop, A.M. Sheehy, H.M. Craig, S.K. Petersen-Mahrt, I.N. Watt, M.S. Neuberger, and M.H. Malim DNA deamination mediates innate immunity to retroviral infection Cell 113 6 2003 803 809
19. G. Hassaine, M. Courcoul, G. Bessou, Y. Barthalay, C. Picard, D. Olive, Y. Collette, R. Vigne, and E. Decroly The tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral vif protein J. Biol. Chem. 276 20 2001 16885 16893
20. A. Jarmuz, A. Chester, J. Bayliss, J. Gisbourne, I. Dunham, J. Scott, and N. Navaratnam An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22 Genomics 79 3 2002 285 296
21. S. Kao, M.A. Khan, E. Miyagi, R. Plishka, A. Buckler-White, and K. Strebel The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity J. Virol. 77 21 2003 11398 11407
22. M.A. Khan, C. Aberham, S. Kao, H. Akari, R. Gorelick, S. Bour, and K. Strebel Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA J. Virol. 75 16 2001 7252 7265
23. M.A. Khan, H. Akari, S. Kao, C. Aberham, D. Davis, A. Buckler-White, and K. Strebel Intravirion processing of the human immunodeficiency virus type 1 Vif protein by the viral protease may be correlated with Vif function J. Virol. 76 18 2002 9112 9123
24. J. Kimpton, and M. Emerman Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene J. Virol. 66 4 1992 2232 2239
25. M. Kishi, Y. Nishino, M. Sumiya, K. Ohki, T. Kimura, T. Goto, M. Nakai, M. Kakinuma, and K. Ikuta Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses J. Gen. Virol. 73 Pt 1 1992 77 87
26. M. Kotler, R.A. Katz, and A.M. Skalka Activity of avian retroviral protease expressed in Escherichia coli J. Virol. 62 8 1988 2696 2700
27. M. Kotler, R.A. Katz, W. Danho, J. Leis, and A.M. Skalka Synthetic peptides as substrates and inhibitors of a retroviral protease Proc. Natl. Acad. Sci. U.S.A. 85 12 1988 4185 4189
28. M. Kotler, G. Arad, and S.H. Hughes Human immunodeficiency virus type 1 gag-protease fusion proteins are enzymatically active J. Virol. 66 11 1992 6781 6783
29. M. Kotler, M. Simm, Y.S. Zhao, P. Sova, W. Chao, S.F. Ohnona, R. Roller, C. Krachmarov, M.J. Potash, and D.J. Volsky Human immunodeficiency virus type 1 (HIV-1) protein Vif inhibits the activity of HIV-1 protease in bacteria and in vitro J. Virol. 71 8 1997 5774 5781
30. H.G. Krausslich Human immunodeficiency virus proteinase dimer as component of the viral polyprotein prevents particle assembly and viral infectivity Proc. Natl. Acad. Sci. U.S.A. 88 8 1991 3213 3217
31. H.G. Krausslich, A.M. Traenckner, and F. Rippmann Expression and characterization of genetically linked homo-and hetero-dimers of HIV proteinase Adv. Exp. Med. Biol. 306 1991 417 428
32. T.H. Lee, J.E. Coligan, J.S. Allan, M.F. McLane, J.E. Groopman, and M. Essex A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses Science 231 4745 1986 1546 1549
33. N. Madani, and D. Kabat An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein J. Virol. 72 12 1998 10251 10255
34. B. Mangeat, P. Turelli, G. Caron, M. Friedli, L. Perrin, and D. Trono Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts Nature 424 6944 2003 99 103
35. R. Mariani, D. Chen, B. Schrofelbauer, F. Navarro, R. Konig, B. Bollman, C. Munk, H. Nymark-McMahon, and N.R. Landau Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif Cell 114 1 2003 21 31
36. M. Marin, K.M. Rose, S.L. Kozak, and D. Kabat HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation Nat. Med. 9 11 2003 1398 1403
37. T.D. Meek, B.D. Dayton, B.W. Metcalf, G.B. Dreyer, J.E. Strickler, J.G. Gorniak, M. Rosenberg, M.L. Moore, V.W. Magaard, and C. Debouck Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease Proc. Natl. Acad. Sci. U.S.A. 86 6 1989 1841 1845
38. A. Mehle, B. Strack, P. Ancuta, C. Zhang, M. McPike, and D. Gabuzda Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway J. Biol. Chem. 279 9 2004 7792 7798
39. A. Ohagen, and D. Gabuzda Role of Vif in stability of the human immunodeficiency virus type 1 core J. Virol. 74 23 2000 11055 11066
40. L.H. Pearl, and W.R. Taylor A structural model for the retroviral proteases Nature 329 6137 1987 351 354
41. M.J. Potash, G. Bentsman, T. Muir, C. Krachmarov, P. Sova, and D.J. Volsky Peptide inhibitors of HIV-1 protease and viral infection of peripheral blood lymphocytes based on HIV-1 Vif Proc. Natl. Acad. Sci. U.S.A. 95 23 1998 13865 13868
42. L. Ratner, W. Haseltine, R. Patarca, K.J. Livak, B. Starcich, S.F. Josephs, E.R. Doran, J.A. Rafalski, E.A. Whitehorn, and K. Baumeister Complete nucleotide sequence of the AIDS virus, HTLV-III Nature 313 6000 1985 277 284
43. A.M. Sheehy, N.C. Gaddis, J.D. Choi, and M.H. Malim Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein Nature 418 6898 2002 646 650
44. A.M. Sheehy, N.C. Gaddis, and M.H. Malim The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif Nat. Med. 9 11 2003 1404 1407
45. J.H. Simon, D.L. Miller, R.A. Fouchier, M.A. Soares, K.W. Peden, and M.H. Malim The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: a role for Vif in determining virus host range and cross-species transmission EMBO J. 17 5 1998 1259 1267
46. J.H. Simon, N.C. Gaddis, R.A. Fouchier, and M.H. Malim Evidence for a newly discovered cellular anti-HIV-1 phenotype Nat. Med. 4 12 1998 1397 1400
47. J.H. Simon, A.M. Sheehy, E.A. Carpenter, R.A. Fouchier, and M.H. Malim Mutational analysis of the human immunodeficiency virus type 1 Vif protein J. Virol. 73 1999 2675 2681
48. J. Sodroski, W.C. Goh, C. Rosen, A. Tartar, D. Portetelle, A. Burny, and W. Haseltine Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions Science 231 4745 1986 1549 1553
49. P. Sova, and D.J. Volsky Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with Vif-negative human immunodeficiency virus type 1 J. Virol. 67 10 1993 6322 6326
50. K. Stopak, C. de Noronha, W. Yonemoto, and W.C. Greene HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability Mol. Cell 12 3 2003 591 601
51. K. Strebel, D. Daugherty, K. Clouse, D. Cohen, T. Folks, and M.A. Martin The HIV 'A' (sor) gene product is essential for virus infectivity Nature 328 6132 1987 728 730
52. B. Teng, C.F. Burant, and N.O. Davidson Molecular cloning of an apolipoprotein B messenger RNA editing protein Science 260 5115 1993 1816 1819
53. X. Yang, J. Goncalves, and D. Gabuzda Phosphorylation of Vif and its role in HIV-1 replication J. Biol. Chem. 271 17 1996 10121 10129
54. X. Yu, Y. Yu, B. Liu, K. Luo, W. Kong, P. Mao, and X.F. Yu Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex Science 302 5647 2003 1056 1060
55. Q. Yu, R. Konig, S. Pillai, K. Chiles, M. Kearney, S. Palmer, D. Richman, J.M. Coffin, and N.R. Landau Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome Nat. Struct. Mol. Biol. 11 5 2004 435 442
56. H. Zhang, B. Yang, R.J. Pomerantz, C. Zhang, S.C. Arunachalam, and L. Gao The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA Nature 424 6944 2003 94 98
57. C. Zimmerman, K.C. Klein, P.K. Kiser, A.R. Singh, B.L. Firestein, S.C. Riba, and J.R. Lingappa Identification of a host protein essential for assembly of immature HIV-1 capsids Nature 415 6867 2002 88 92